Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography

Objectives. Polysorbate 80 (PS80) quantification in biopharmaceutical products has always been challenging owing to its minute content, absorption to the protein backbone, lack of specific chromophoric PS80 groups, and heterogenic nature. This work is aimed at developing an express method for PS80 a...

Full description

Saved in:
Bibliographic Details
Main Authors: A. D. Askretkov, D. O. Shatalov, N. V. Orlova, D. I. Zybin, V. V. Nikolaeva, A. A. Klishin, E. S. Tuzova, D. S. Minenkov, S. A. Kedik, Yu. A. Seregin
Format: Article
Language:Russian
Published: MIREA - Russian Technological University 2022-04-01
Series:Тонкие химические технологии
Subjects:
Online Access:https://www.finechem-mirea.ru/jour/article/view/1798
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839581224002125824
author A. D. Askretkov
D. O. Shatalov
N. V. Orlova
D. I. Zybin
V. V. Nikolaeva
A. A. Klishin
E. S. Tuzova
D. S. Minenkov
S. A. Kedik
Yu. A. Seregin
author_facet A. D. Askretkov
D. O. Shatalov
N. V. Orlova
D. I. Zybin
V. V. Nikolaeva
A. A. Klishin
E. S. Tuzova
D. S. Minenkov
S. A. Kedik
Yu. A. Seregin
author_sort A. D. Askretkov
collection DOAJ
description Objectives. Polysorbate 80 (PS80) quantification in biopharmaceutical products has always been challenging owing to its minute content, absorption to the protein backbone, lack of specific chromophoric PS80 groups, and heterogenic nature. This work is aimed at developing an express method for PS80 analysis in biopharmaceutical products using hydrolysis and subsequent highperformance liquid chromatography analysis with ultraviolet detection that does not consume substantial amounts of sample (≥35 μL).Methods. Five therapeutic protein formulations were chosen as model proteins. Alkaline hydrolysis formulation was applied, without protein precipitation and with a range of precipitation techniques to remove protein from the test solution and hydrolyze PS80, to free fatty acids. The obtained hydrolysate was analyzed using reverse-phase high-performance liquid chromatography.Results. As a result of the high protein content of monoclonal antibody formulations, preliminary protein removal was required, which was achieved by precipitation with organic solvents. A specific precipitant ethanol–isopropanol mixture (1:1 volumetric ratio) was developed to efficiently remove antibodies while keeping PS80 in the solution. The PS80 quantification method was developed for monoclonal antibody drugs. For three monoclonal antibody drug products (adalimumab, infliximab, and eculizumab), method validation was performed according to the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use, the United States Pharmacopeia, and the State Pharmacopeia of the Russian Federation guidelines.Conclusions. The optimal assay conditions for each group of recombinant monoclonal antibody substances were chosen. Protein precipitation with ethanol or ethanol–isopropanol mixtures before hydrolysis was introduced, allowing for a substantial reduction of sample to 35 μL or even less if PS80 content is higher than 0.05 mg/mL. Accelerated hydrolysis (90 min) is preferable to slow hydrolysis (4–18 h). Method validation for protein products such as adalimumab, infliximab, and eculizumab was demonstrated for the first time. Both methods were validated for each drug product. The coefficients of variation for method specificity and high precision were ≤6.0% for 3 analyses. The accuracy of the methods ranged from 96% to 109% for all of the tested drug products.
format Article
id doaj-art-7d34d87b7de84c06b4d7c87d3739d68e
institution Matheson Library
issn 2410-6593
2686-7575
language Russian
publishDate 2022-04-01
publisher MIREA - Russian Technological University
record_format Article
series Тонкие химические технологии
spelling doaj-art-7d34d87b7de84c06b4d7c87d3739d68e2025-08-04T10:19:40ZrusMIREA - Russian Technological UniversityТонкие химические технологии2410-65932686-75752022-04-01171394910.32362/2410-6593-2022-17-1-39-491667Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatographyA. D. Askretkov0D. O. Shatalov1N. V. Orlova2D. I. Zybin3V. V. Nikolaeva4A. A. Klishin5E. S. Tuzova6D. S. Minenkov7S. A. Kedik8Yu. A. Seregin9MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)MIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)Scientific Center “Kurchatov Institute,” Research Institute for Genetics and Selection of Industrial MicroorganismsPHARMAPARK LLCScientific Center “Kurchatov Institute,” Research Institute for Genetics and Selection of Industrial MicroorganismsScientific Center “Kurchatov Institute,” Research Institute for Genetics and Selection of Industrial MicroorganismsScientific Center “Kurchatov Institute,” Research Institute for Genetics and Selection of Industrial MicroorganismsIshlinsky Institute for Problems in Mechanics, Russian Academy of SciencesMIREA – Russian Technological University (M.V. Lomonosov Institute of Fine Chemical Technologies)PHARMAPARK LLCObjectives. Polysorbate 80 (PS80) quantification in biopharmaceutical products has always been challenging owing to its minute content, absorption to the protein backbone, lack of specific chromophoric PS80 groups, and heterogenic nature. This work is aimed at developing an express method for PS80 analysis in biopharmaceutical products using hydrolysis and subsequent highperformance liquid chromatography analysis with ultraviolet detection that does not consume substantial amounts of sample (≥35 μL).Methods. Five therapeutic protein formulations were chosen as model proteins. Alkaline hydrolysis formulation was applied, without protein precipitation and with a range of precipitation techniques to remove protein from the test solution and hydrolyze PS80, to free fatty acids. The obtained hydrolysate was analyzed using reverse-phase high-performance liquid chromatography.Results. As a result of the high protein content of monoclonal antibody formulations, preliminary protein removal was required, which was achieved by precipitation with organic solvents. A specific precipitant ethanol–isopropanol mixture (1:1 volumetric ratio) was developed to efficiently remove antibodies while keeping PS80 in the solution. The PS80 quantification method was developed for monoclonal antibody drugs. For three monoclonal antibody drug products (adalimumab, infliximab, and eculizumab), method validation was performed according to the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use, the United States Pharmacopeia, and the State Pharmacopeia of the Russian Federation guidelines.Conclusions. The optimal assay conditions for each group of recombinant monoclonal antibody substances were chosen. Protein precipitation with ethanol or ethanol–isopropanol mixtures before hydrolysis was introduced, allowing for a substantial reduction of sample to 35 μL or even less if PS80 content is higher than 0.05 mg/mL. Accelerated hydrolysis (90 min) is preferable to slow hydrolysis (4–18 h). Method validation for protein products such as adalimumab, infliximab, and eculizumab was demonstrated for the first time. Both methods were validated for each drug product. The coefficients of variation for method specificity and high precision were ≤6.0% for 3 analyses. The accuracy of the methods ranged from 96% to 109% for all of the tested drug products.https://www.finechem-mirea.ru/jour/article/view/1798polysorbate 80hydrolysishplcoleic acidtherapeutic proteinsspectrophotometric detection
spellingShingle A. D. Askretkov
D. O. Shatalov
N. V. Orlova
D. I. Zybin
V. V. Nikolaeva
A. A. Klishin
E. S. Tuzova
D. S. Minenkov
S. A. Kedik
Yu. A. Seregin
Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography
Тонкие химические технологии
polysorbate 80
hydrolysis
hplc
oleic acid
therapeutic proteins
spectrophotometric detection
title Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography
title_full Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography
title_fullStr Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography
title_full_unstemmed Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography
title_short Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography
title_sort quantitation of polysorbate 80 in recombinant protein formulation using high performance liquid chromatography
topic polysorbate 80
hydrolysis
hplc
oleic acid
therapeutic proteins
spectrophotometric detection
url https://www.finechem-mirea.ru/jour/article/view/1798
work_keys_str_mv AT adaskretkov quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT doshatalov quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT nvorlova quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT dizybin quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT vvnikolaeva quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT aaklishin quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT estuzova quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT dsminenkov quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT sakedik quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography
AT yuaseregin quantitationofpolysorbate80inrecombinantproteinformulationusinghighperformanceliquidchromatography